Keitel, W A <br/><br/>
Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoid.  [electronic resource] 

 -  Vaccine  Oct 1999 
 - 531-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0264-410X 
<br/><br/><label>Standard No.: </label>10.1016/s0264-410x(99)00221-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Animals<br/>Antibodies, Protozoan--blood<br/>Epitopes, T-Lymphocyte<br/>Humans<br/>Lymphocyte Activation<br/>Malaria Vaccines--adverse effects<br/>Merozoite Surface Protein 1--immunology<br/>Middle Aged<br/>Peptide Fragments--immunology<br/>Plasmodium falciparum--immunology<br/>Skin Tests<br/>T-Lymphocytes, Helper-Inducer--immunology<br/>Tetanus Toxoid--immunology<br/>Vaccines, Synthetic--immunology